Skin lesions (head, face, trunk, hands, genitals) Referral Access Criteria

Referrers should use this page when referring patients to public adult plastics and reconstructive surgery outpatient services for skin lesions (head, face, trunk, hands, genitals).
Emergency referral
If any of the following are present or suspected, refer the patient to the emergency department or seek emergency medical advice if in a remote region.
  • Nil
Immediate referral
Orange exclamation mark in triangle: orange alertImmediately contact the on-call registrar or service to arrange an immediate plastics and reconstructive surgery assessment (seen within 7 days): 
  • Nil
Clinical indications for outpatient referral
If any of these issues are present, refer to outpatient services through the Central Referral Service (CRS).
  • Skin cancer/lesion
  • Technically difficult non-melanoma lesions – consider referral to Plastic and Reconstructive Surgery for specialist assessment of lesions located on:
    • face, especially if greater than 5mm diameter, where scarring may be problematic
    • scalp, especially if greater than 10mm diameter unless direct closure is possible
    • trunk or extremity lesion greater than 15mm diameter (e.g. potentially requiring a graft)
    • periocular region, ears, lips, nose
    • nipple, genitalia
    • wrist, hand
  • Recurrence, or near a previously treated area
  • Rapidly growing
  • Extending beyond subcutaneous tissue
  • Persisting cosmesis concern after risk discussion (including scar revision of any region not related to cancer treatment)
Mandatory information

Referrals missing 'mandatory information' with no explanation provided may not be accepted by site. If 'mandatory information' is not included, the explanation must be provided in the body of the referral (e.g. patient unable to access test in regional or remote areas or due to financial reasons). This information is required to inform accurate and timely triage.

If unable to attach reports, please include relevant information/findings in the body of the referral and advise where (provider) investigation/imaging was completed.

History
  • Relevant history, onset and duration of symptoms including detailed location and any change over time
  • Current medication list
  • Any known allergies
  • Previous history of malignant melanoma (MM) or non-melanoma skin cancer (NMSC)
Examination
  • Features of pigmented lesions: size, shape, colour, inflammation, oozing, change in sensation

Investigations
  • Biopsy results unless clinically contraindicated or technically not feasible
    Note, below information for referrer only
    • for suspected melanoma:
      • the optimal biopsy approach is an excisional biopsy with 2mm margins. If this is not feasible, an incisional biopsy may be considered.
      • where an excisional or incisional biopsy is not feasible, a large punch biopsy (>5mm) may be considered. A shave biopsy is not recommended by WA Kirkbride Melanoma Advisory Service (WAKMAS) guidelines.
    • for basal cell carcinoma and squamous cell carcinoma:
      • punch or excisional biopsy to allow for surgical planning (punch biopsy preferred if lesion is large and not amenable to excisional biopsy with 2mm margin)
Highly desirable
History
  • Family history of skin cancer
  • Details of smoking and/or vaping (containing nicotine) status
  • Advise whether or not your patient is taking any anti-platelets or anti-coagulants
    • if so, please state the indication
Examination
  • Photograph or diagram of the area/biopsied site
  • BMI
Investigations
  • Ultrasound (US) lesion (for atypical lipoma)

Indicative clinical urgency category

Category 1

Appointment within 30 days

  • Skin lesion highly suspicious for melanoma or excision biopsy proven melanoma or SCC (over 10mm diameter in a cosmetically sensitive area)
  • Uncomplicated non-melanoma skin malignancies (BCC/SCC)
  • Rapidly growing skin lesions especially on the face
  • Suspicion of malignant liposarcoma
  • Complex non-melanoma skin malignancies and any of the following:
    • ulceration and bleeding
    • rapidly enlarging
    • neurological involvement
    • lymphadenopathy
    • poorly differentiated or infiltrative tumour on biopsy
  • Skin lesions with any of the following:
    • causing substantial obstruction to vision
    • causing functional problems or significant disfigurement
    • diameter exceeds ≥ 5cm in size or rapid growth over short period of time
    • severe persistent pain that is not solely pressure related
    • fixed to deep tissues i.e. muscle or fascia

Category 2

Appointment within 90 days

  • Skin lesions with any of the following:
    • recurring after a previous excision
    • prone to recurrent infection
    • diagnosis in doubt or needs confirmation

Category 3

Appointment within 365 days

  • Symptomatic benign soft tissue lesions e.g. lipoma, ganglion
  • Non-suspicious moles which are regularly traumatised
Exclusions
Useful information

Feedback

If you would like to submit feedback on the contents of the Referral Access Criteria, please complete this form.

Last reviewed: 15-08-2025